OR WAIT null SECS
July 08, 2026
Article
Catch up on some of the biggest FDA news, clinical trial updates, and featured HCPLive coverage from the first half of 2026.
June 30, 2026
FDA sends fresh CRL for Unicycive’s OLC; manufacturing inspection delays approval, while data support a lower pill-burden phosphate binder.
June 24, 2026
Katherine Tuttle, MD, discusses shifting the goals of chronic kidney disease management from slowing progression to preserving kidney function.
June 21, 2026
Butler explains why the urine albumin-to-creatinine ratio belongs in routine heart failure risk assessment and where the open questions remain.
Podcast
Phase 3 FIND-CKD data show finerenone slows kidney function decline in non-diabetic chronic kidney disease, extending the agent's role beyond diabetic CKD.
June 13, 2026
New systematic review of 7012 kidney transplant recipients with T2D finds GLP-1 receptor agonists cut major adverse kidney events and mortality by 61%.
June 03, 2026
Catch up on the key nephrology news, research findings, and expert insights featured on HCPLive throughout May 2026.
June 02, 2026
Phase 3 post hoc data linked lorundrostat to lower systolic blood pressure and albuminuria in patients with hypertension and CKD.
May 21, 2026
The FDA accepted Bayer’s sNDA for finerenone in adults with type 1 diabetes and CKD based on albuminuria data from FINE-ONE.
April 24, 2026
Video
Gill describes how storytelling and patient representation can build trust and education in Indigenous populations regarding transplantation.
